Bridging the Gap - Users' and payers' perspectives

Thursday, June 3


About Tal Golesworthy | Technical Director, Exstent Ltd.

Tal Golesworthy
, is a Chartered Engineer, Member of the Energy Institute and the Royal Society of Chemistry with 43 years Research & Development experience, 17 years at the National Coal Board’s Coal Research Establishment, including 3 years training as a patent agent, and 26 years a director of Environmental Development Technology Ltd running R&D projects in combustion and flue gas cleaning/Air Pollution Control.

As a Marfan Syndrome patient with aortic dilation, Tal was unimpressed with the options of a Total Root Replacement (TRR or Bentall) or Valve Sparing Root Replacement (VSRR) so set about engineering an alternative. 16 years after receiving the first personalised external aortic root support (PEARS) himself, he is now working to extend this surgical option to a wider group of patients with aortic dilation.

With NICE IPAC approval, 31 surgical centres up and running, 400+ patients successfully treated, and a collective 1500+ post operative patient years, PEARS continues to progress.

March 2014 saw the TED talk on the PEARS project break 1,000,000 viewings (https://www.ted.com/talks/tal_golesworthy_how_i_repaired_my_own_heart?language=en)

July 2015 saw Tal receive one of the first Patient Innovation Awards in Lisbon (http://us3.campaign-archive1.com/?u=7ed42017b5a721b88e1910afb&id=2d6c3fee79)

PEARS is now written up in 46 peer reviewed journal papers and has been presented at various major international conferences.

Married for 40 years to Teresa, Tal has some time for clay pigeon shooting, deer stalking, music, and 20 century European history.




About Exstent

Exstent was formed in 2002 by Tal Golesworthy to develop and manufacture the ExoVasc® Personalised External Aortic Root Support. This innovative device is used to externally support the weakened aorta in patients with connective tissue disorders at risk of aortic dilatation and dissection. Having invented this minimally invasive alternative to conventional surgery involving aortic root replacement, Tal Golesworthy became the first patient to receive the personalised ExoVasc implant in 2004, and since then the device has benefitted over 450 other patients.

Powered by:
Hyphen Projects   

    Connect with us                  

Join GAINH

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 
                                    

Register
© Copyright 2020 by Hyphen Projects